146 related articles for article (PubMed ID: 37851086)
1. Treating rare tumors with liver transplantation.
Melehy A; Agopian V
Curr Opin Organ Transplant; 2024 Feb; 29(1):30-36. PubMed ID: 37851086
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation for hepatic tumors: a systematic review.
Ravaioli M; Ercolani G; Neri F; Cescon M; Stacchini G; Del Gaudio M; Cucchetti A; Pinna AD
World J Gastroenterol; 2014 May; 20(18):5345-52. PubMed ID: 24833864
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for malignancies.
Eghtesad B; Aucejo F
J Gastrointest Cancer; 2014 Sep; 45(3):353-62. PubMed ID: 24604263
[TBL] [Abstract][Full Text] [Related]
4. Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single-center experience (1981-2015).
Vinayak R; Cruz RJ; Ranganathan S; Mohanka R; Mazariegos G; Soltys K; Bond G; Tadros S; Humar A; Marsh JW; Selby RR; Reyes J; Sun Q; Haberman K; Sindhi R
Liver Transpl; 2017 Dec; 23(12):1577-1588. PubMed ID: 28834194
[TBL] [Abstract][Full Text] [Related]
5. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
[TBL] [Abstract][Full Text] [Related]
6. Liver Transplantation for Hepatic Epithelioid Hemangioendothelioma Is Facilitated by Exception Points With Acceptable Long-term Outcomes.
Brahmbhatt M; Prenner S; Bittermann T
Transplantation; 2020 Jun; 104(6):1187-1192. PubMed ID: 31577674
[TBL] [Abstract][Full Text] [Related]
7. Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.
Lunsford KE; Court C; Seok Lee Y; Lu DS; Naini BV; Harlander-Locke MP; Busuttil RW; Agopian VG
Liver Transpl; 2018 Oct; 24(10):1384-1397. PubMed ID: 29573187
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation for unresectable neuroendocrine tumor liver metastases.
Rossi RE; Burroughs AK; Caplin ME
Ann Surg Oncol; 2014 Jul; 21(7):2398-405. PubMed ID: 24562931
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in patients with recurrent hepatocellular carcinoma treated with salvage liver transplantation: a single-center study.
Wang P; Li H; Shi B; Que W; Wang C; Fan J; Peng Z; Zhong L
Oncotarget; 2016 Jun; 7(23):35071-83. PubMed ID: 27145461
[TBL] [Abstract][Full Text] [Related]
10. Treatment of recurrent hepatocellular carcinoma after liver transplantation.
Kim HR; Cheon SH; Rha SY; Lee S; Han KH; Chon CY; Lee JD; Sung JS; Chung HC
Asia Pac J Clin Oncol; 2011 Sep; 7(3):258-69. PubMed ID: 21884437
[TBL] [Abstract][Full Text] [Related]
11. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
[TBL] [Abstract][Full Text] [Related]
12. Twenty-year experience with liver transplantation for hepatocellular carcinoma.
Island ER; Pomposelli J; Pomfret EA; Gordon FD; Lewis WD; Jenkins RL
Arch Surg; 2005 Apr; 140(4):353-8. PubMed ID: 15837885
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation for hepatic epithelioid hemangioendothelioma: the Canadian multicentre experience.
Nudo CG; Yoshida EM; Bain VG; Marleau D; Wong P; Marotta PJ; Renner E; Watt KD; Deschênes M
Can J Gastroenterol; 2008 Oct; 22(10):821-4. PubMed ID: 18925305
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for malignant diseases: selection and pattern of recurrence.
Margarit C; Charco R; Hidalgo E; Allende H; Castells L; Bilbao I
World J Surg; 2002 Feb; 26(2):257-63. PubMed ID: 11865357
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
Zou WL; Zang YJ; Chen XG; Shen ZY
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
[TBL] [Abstract][Full Text] [Related]
16. Outcome of liver transplantation for hepatocellular carcinoma -- a single center experience.
Iacob R; Iacob S; Gheorghe L; Gheorghe C; Hrehoreţ D; Brașoveanu V; Croitoru A; Herlea V; Popescu I
Chirurgia (Bucur); 2013; 108(4):446-50. PubMed ID: 23958083
[TBL] [Abstract][Full Text] [Related]
17. Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series.
Sapisochin G; Bilbao I; Balsells J; Dopazo C; Caralt M; Lázaro JL; Castells L; Allende H; Charco R
World J Surg; 2010 Sep; 34(9):2146-54. PubMed ID: 20411387
[TBL] [Abstract][Full Text] [Related]
18. Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma.
Hakeem AR; Young RS; Marangoni G; Lodge JP; Prasad KR
Aliment Pharmacol Ther; 2012 May; 35(9):987-99. PubMed ID: 22429190
[TBL] [Abstract][Full Text] [Related]
19. Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant.
Cucchetti A; Serenari M; Sposito C; Di Sandro S; Mosconi C; Vicentin I; Garanzini E; Mazzaferro V; De Carlis L; Golfieri R; Spreafico C; Vanzulli A; Buscemi V; Ravaioli M; Ercolani G; Pinna AD; Cescon M
J Hepatol; 2020 Aug; 73(2):342-348. PubMed ID: 32201284
[TBL] [Abstract][Full Text] [Related]
20. Mixed Hepatocellular Cholangiocarcinoma: A Review of Long-Term Outcomes Following Liver Transplantation.
Machairas N; Stamopoulos P; Kostakis ID; Garoufalia Z; Paspala A; Tsaparas P; Sotiropoulos GC
Transplant Proc; 2019 Mar; 51(2):437-439. PubMed ID: 30879560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
